M&A M&A
Russia's Binnopharm to acquire anti-bacterial brands from Dr Reddy's Labs
Source BSE Disclosure (opens in a new tab)Press Release (opens in a new tab)
Russian pharmaceutical company Binnopharm, a Sistema Group company, via its affiliate Joint Stock Company 'Alium', and Dr. Reddy's Laboratories Ltd, an integrated global pharmaceutical company, have signed a deal that will allow Binnopharm Group to acquire anti-bacterial medicines under the Ciprolet® and Levolet® brands from Dr. Reddy's in Russia, Uzbekistan and Belarus. The portfolio includes various dosage forms such as tablets, solution for infusions and eye drops.